Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-656-8 | CAS number: 109-21-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
For this enpoint, read-across information on the source substance ethyl hexanoate is available.
In a combination of three in vitro methods, protein reactivity (DPRA), activation of keratinocytes (LuSens) and activation of dendritic cells (h-CLAT) were measured to assess the potential for skin sensitization using the in vitro Skin Sensitization Turnkey Testing Strategy to address key events of the adverse outcome pathway (AOP).
Based on the results and applying the evaluation criteria ethyl hexanoate is not peptide reactive, does not activate keratinocytes and activates dendritic cells, and is according to the evaluation criteria predicted not to be a skin sensitizer.
As a consequence, the target substance butyl butyrate was also considered to be not a skin sensitizer.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 16.03.2015 - 23.03.2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Read-across from ethyl hexanoate to butyl butyrate is considered justified based on strong similarities with regard to chemical structure and metabolic pathways. A full read-across justification including comparison of toxicological profiles will be included in section 13 of the IUCLID dossier.
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Run / experiment:
- other: C-containing peptide (mM)
- Parameter:
- other: Peptide depletion
- Value:
- 0
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Run / experiment:
- other: K-containing peptide (mM)
- Parameter:
- other: Peptide depletion
- Value:
- 0
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Parameter:
- other: Mean peptide depletion
- Value:
- 0
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Other effects / acceptance of results:
- The mean peptide depletion of the positive control was 34.77%.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance ethyl hexanoate shows no chemical reactivity in the DPRA test under the current conditions. Read-across was done from ethyl hexanoate to butyl butyrate based on the structural, chemical and toxicological similarities between ethyl hexanoate and butyl butyrate. Therefore, the test substance butyl butyrate is to be considered as a nonsensitiser.
- Executive summary:
Read-across was done from ethyl hexanoate.
In the current study the skin sensitisation effect of the test item was assessed in an in chemico assay according to OECD 442C.
This method quantifies the remaining concentrations of cysteine- or lysine-containing peptides after 24 hours incubation with the test item at 25 +/-2.5 °C. The percentage of depletion of cysteine- and lysine-peptides is calculated and used in a prediction model to assign the test chemical to one of four reactivity classes and in this way discriminate between sensitisers and non-sensitisers.
The test item was dissolved at a 100 mM concentration in acetonitrile (ACN) and 3 samples of the test item were incubated with a typical concentration of 0.667 mM of cysteine in a pH 7.5 phosphate buffer or 0.667 mM of lysine in a pH 10.2 ammonium acetate buffer. Incubation was done for 24 hours in the dark at 25 +/- 2.5°C. The remaining non-depleted concentrations were determined by HPLC with gradient elution and UV-detector at 220 nm.
The mean C-peptide depletion, caused by the test substance was determined to be -0.52%.
The mean K-peptide depletin, caused by the test substance was determined to be -0.04%.
Negative depletions are considered to be "zero" for the calculation of the mean peptide depletion, resulting in 0.0% for the test item. Based on the results and the prediction model, it is concluded that ethyl hexanoate shows no chemical reactivity in the DPRA test under the current conditions.
Based on this result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and butyl butyrate, butyl butyrate is considered to be not sensitising.
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 23.04.2015 - 28.08.2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Read-across from ethyl hexanoate to butyl butyrate is considered justified based on strong similarities with regard to chemical structure and metabolic pathways. A full read-across justification including comparison of toxicological profiles will be included in section 13 of the IUCLID dossier.
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Parameter:
- other: RFI CD54 mean (%) and RFI CD54 mean (%)
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The test substance ethyl hexanoate induces dendritic cell activation (CD54 expression increased =200% in at least one assay) in the h-CLAT test under the current conditions. Read-across was done from ethyl hexanoate to butyl butyrate based on the structural, chemical and toxicological similarities between ethyl hexanoate and butyl butyrate. Therefore, the test substance butyl butyrate is to be considered as a sensitiser.
- Executive summary:
Read-across was done from ethyl hexanoate.
In the current study the skin sensitisation potential of the test item was assessed according to a new guideline on In Vitro Skin Sensitization: human Cell Line Activation Test (h-CLAT) accessed on 01 September 2014.
The potential of the test substance to induce the cell membrane markers CD86 and CD54 expression was evaluated in the human Cell Line Test (h-CLAT). The test substance was incubated with the human pro-monocytic cell line THP-1 for 24 hours at 37°C and the membrane markers expression was measured by flow cytometry through staining with FITC labeled anti-human-CD86/anti human CD54 antibody and propidium iodide.
In order to determine the concentration suitable for the main test a pre-test was performed.
The CV75 value (= estimated concentration that affords 75% cell viability) was determined by linear regression from the concentration response curve.
In the main experiment the test item was tested at concentrations of 566 μg/mL onwards (1st experiment: 2027, 1689, 1408, 1173, 977, 815, 679 and 566 µg/mL; 2nd experiment: 1173, 977, 815, 679, 566, 471, 393 and 327 µg/mL). No precipitates were noticed in any concentration after 24 hours.
Relative fluorescence intensity and concurrent relative viability were determined in 2 main experiments. Calculation of an EC150 (the concentration resulting in a RFI of 150) for CD86 and an EC200 (the concentration resulting in a RFI of 200) for CD54 was not applicable.
In summary, after 24 hours of exposure to the test substance ethyl hexanoate, CD54 expression was induced in THP-1 cells affording at least 50% viability in at least two independent experiments. From this it has to be concluded that test substance ethyl hexanoate
induces dendritic cell activation.
Based on this result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and butyl butyrate, butyl butyrate is considered to be a sensitiser.
.
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 23.03.2015 - 27.04.2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Read-across from ethyl hexanoate to butyl butyrate is considered justified based on strong similarities with regard to chemical structure and metabolic pathways. A full read-across justification including comparison of toxicological profiles will be included in section 13 of the IUCLID
dossier. - Reason / purpose for cross-reference:
- read-across source
- Parameter:
- other: fold increase and cell viability
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance ethyl hexanoate did not show any keratinocyte activating potential in the LuSens test under the current conditions. Read-across was done from ethyl hexanoate to butyl butyrate based on the structural, chemical and toxicological similarities between ethyl hexanoate and butyl butyrate. Therefore, the test substance butyl butyrate is to be considered as a nonsensitiser.
- Executive summary:
Read-across was done from ethyl hexanoate.
In the current study on ethyl hexanoate the skin sensitising potential of the test item was assessed according to OECD 442D without significant deviations and GLP.
The keratinocyte activating potential of test substance was evaluated in the LuSens assay. The test substance was incubated with a luciferase reporter cell line (LuSens cells) for 48 hours at 37°C and the antioxidant response element (ARE) dependent luciferase activity was measured.
In order to determine the concentrations suitable for the main experiment a pre-test was performed in which cells were exposed to 9 concentrations and the cytotoxicity was determined by MTT assay. The CV75 value (=estimated concentration that affords 75% cell viability) was determined by linear regression from the concentration response curve.
In the main test the luciferase activity was measured and in parallel a MTT assay was performed to assess the cytotoxicity of the test substance. The experiment was done in triplicate. The test substance was dissolved in 4% DMSO and in the end 1% DMSO was present in culture at all concentrations. No precipitates were noticed in any preparations.
The acceptance criteria were met.
Exposure to the test substance did not induce a statistical significant 1.5 fold increase in luciferase activity in LuSens cells while 70% viability was reached. Concluding, ethyl hexanoate did not show any keratinocyte activating potential and thus is to be considered as a non-sensitiser.
Based on this result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and butyl butyrate, butyl butyrate is considered to be not sensitising.
.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
For this endpoint there are 3 studies available on the read-across substance ethyl hexanoate.
To evaluate the skin sensitisation effects of ethyl hexanoate a combination of 3 in vitro methods addressing the key events of the adverse outcome pathway (AOP) for skin sensitization were performed. The tests are the Direct Peptide Reactivity Assay (DPRA), the ARE Reporter Assay (LuSens) and the Dendritic Cell Line Activation Assay (h-CLAT).
DPRA test
In the DPRA test (OECD 442C) the reactivity of ethyl hexanoate towards synthetic cysteine (C)- or lysine (K)- containing peptides was evaluated. Incubation of the synthetic peptides with ethyl hexanoate was done for 24 hours and the remaining concentrations of cysteine- or lysine-containing peptides were determined.
The mean C-peptide depletion, caused by the test substance was determined to be -0.52%.
The mean K-peptide depletion, caused by the test substance was determined to be -0.04%.
Based on the observed results and applying the prediction model proposed in Gerberick et. al (2007) it is concluded that ethyl hexanoate shows no chemical reactivity in the DPRA test under the current conditions.
LuSens test
In the LuSens assay (OECD 442D) the keratinocyte activating potential of ethyl hexanoate was evaluated. Ethyl hexanoate was incubated with a luciferase reporter cell line (LuSens cells) for 48 hours and the antioxidant response element (ARE) dependent luciferase activity was measured, in parallel to a MTT assay to assess the cytotoxicity. No precipitates were noticed in any preparations. The acceptance criteria were met. After exposure to ethyl hexanoate activity in LuSens cells was not induced significantly in at least two consecutive concentrations affording at least 70% viability in at least two independent experiments. It has to be concluded that test substance ethyl hexanoate does not have a keratinocyte activating potential.
h-CLAT test
In the third in vitro study (OECD 442E) the potential of ethyl hexanoate to induce the expression of the cell membrane markers CD86 and CD54 in the human Cell Line Test (h-CLAT) was evaluated. In the human pro-monocytic cell line THP-1 the change in the expression of the cell membrane markers is measured by flow cytometry after 24 hours of test substance exposure through staining with FITC labeled anti-human-CD86/anti human CD54 antibody and propidium iodide.
No precipitates were noticed at any concentration.Calculation of an EC150 (the concentration resulting in a RFI of 150) for CD86 and an EC200 (the concentration resulting in a RFI of 200) for CD54 was not applicable.
In summary, after 24 hours of exposure to test substance ethyl hexanoate CD54 expression was induced in THP-1 cells affording at least 50% viability in at least two independent experiments. From this it has to be concluded that test substance ethyl hexanoate induces dendritic cell activation.
The test battery evaluation uses the results of the three individual assays reflecting three key events along the adverse outcome pathway leading to skin sensitization. In the test battery a weight of evidence approach is made in such a way that any 2 out of 3 tests determine the overall result (2 positive test results drive the prediction of a sensitizer, while 2 negative test results drive the prediction of a non-sensitizer). In the case of ethyl hexanoate 2 of the tests are negative and 1 is positive. Applying the evaluation criteria ethyl hexanoate is predicted not to be a skin sensitizer.
Conclusion
Based on this result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and butyl butyrate, butyl butyrate is not considered to be a skin sensitizer.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The criteria to evaluate a substance for the skin sensitisation endpoint using the in vitro Skin Sensitization Turnkey Testing Strategy to address key events of the adverse outcome pathway (AOP) according to the CLP Regulation (EC) No 1272/2008 were fulfilled. In the case of ethyl hexanoate 2 of the tests are negative and 1 is positive. Applying the evaluation criteria ethyl hexanoate is predicted not to be a skin sensitizer.
Based on this result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and butyl butyrate, butyl butyrate is not considered to be a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.